Jamie Chaft

Saturday Morning Live From NY! The 20th @gotoPER NY Lung Cancers meeting is on the way and while not drinking age yet but now has grown up and needs a larger room! Great start w amazing faculty and terrific co-chair- @ChaftJamie! U can still take the NYC subway, LIRR, Metro North or NJ transit to join us to celebrate and learn together how to do even better for our patients w lung cancer in the next 20 yrs!

🗽 NYC is calling!
This November, join me and Balazs Halmos, MD, MS at the 20th Annual New York Lung Cancers Symposium®. 💡 HCPs register FREE with code CHAFT
🗓 Nov. 15, 2025 | 📍 New York Hilton Midtown Secure your spot now ➡️ tinyurl.com/2ywa7fxz @gotoper_ #NYL25

Published in today’s print edition of @NEJM the final survival results of neoadjuvant nivo in lung cancer along with a 2 min quick take video & an elegant editorial from Dr. @VirginiaCalvo6 ! #LCSM @gecp_org nejm.org/do/10.1056/NEJ…

Striking activity with ABBV-706 SEZ6 ADC in high grade neuroendocrine cancer (NECs) where active therapies are urgently needed. Thank you to the patients and their families. @alissajcooper #LCSM

At @ASCO, scientists from MSK presented promising results on three different targeted therapies — one for #smallcell #lungcancer and two for #nonsmallcell lung cancer. Read more from thoracic medical oncologists @charlesrudin, @HelenaYu923, and @ChaftJamie: bit.ly/4mJxUHU #ASCO25

Great discussions w Drs. ⁦@ChaftJamie & ⁦⁦@SBroderickMD⁩ on practical immunotherapy in early stage lung cancer! Answers in CME - A Continuous Road to Clinical Improvement: Examining Immunotherapeutic Regimens for Resectable, Early-Stage NSCLC answersincme.com/RUX?interactio…

Wonderful faculty for 3rd Annual Summit on Thoracic Malignancies in Kona Hawaii @DAVAOnc honored to co-chair with #johnheymach & #natashaleighl with over 90 phenomenal faculty

FDA officials raise concerns with immunotherapy overuse for early-stage cancer patients: #AACR24 – Endpoints News endpts.com/fda-officials-…